Our Patented Method
A Proven, Patented Method for Predicting and Evaluating Antimicrobial Therapy
When molecular PCR testing identifies multiple organisms and multiple resistance genes from a single DNA sample, determining the most appropriate treatment can become incredibly complex.
ATA Consults was built to solve that problem.
ATA CEO and molecular pharmacist, Dr. Robin Prince, is the inventor of ATA’s patented method for predicting and evaluating antimicrobial therapy when molecular PCR testing results identify multi-organism and multi-resistant bacteria from a single DNA sample.
This methodology provides a structured, clinically informed approach to interpreting complex molecular results and helping providers determine appropriate pharmaceutical options for their patients.
More Than Identifying What’s Present
A PCR report can identify organisms and resistance genes. The greater challenge is understanding what those findings mean together.
ATA’s patented methodology addresses critical questions such as:
- How resistance genes should be mapped to specific organisms
- Which organisms and resistance markers are clinically significant
- How potential treatment options can be systematically evaluated
- When antibiotic intervention may be appropriate
- How complex multi-organism results can be translated into practical clinical guidance
Our comprehensive approach combines molecular science with pharmacist-led clinical interpretation to help providers move from complicated laboratory data to informed treatment decisions.
Authentic Analysis Making a Difference
ATA’s methodology was developed from scratch through years of clinical experience, case analysis, and direct work with complex molecular diagnostic results.
It was created before the emergence of today’s AI-driven clinical tools and built with one purpose in mind: to serve as a meaningful medical resource for providers making difficult antimicrobial decisions.
The patented process reflects ATA’s commitment to authentic analysis—not simply generating another automated result.
Helping Thousands of Providers Make Solid Antibiotic Decisions for Their Patients
The patent process included the submission of extensive clinical examples demonstrating how ATA’s methodology could be applied to complex patient cases.
Today, ATA helps thousands of providers across the country interpret molecular testing results and make more informed antibiotic decisions for their patients.
Behind every recommendation is a methodology designed to connect molecular findings with the clinical realities of patient care.
Authentic Analysis. Meaningful Guidance.
Technology can identify what is present.
ATA helps providers understand what to do with that information.
Our patented methodology, combined with the expertise of molecular pharmacists, gives providers an additional layer of clinical insight when navigating complicated infections, resistance patterns, and antimicrobial therapy decisions.
Because better interpretation can lead to better decisions—and better decisions can make a meaningful difference for patients.
Put Complex Molecular Data to Work
Learn how ATA Consults can help your organization turn complex PCR results into actionable clinical guidance.